Novo Resources Quote - NVO

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Premium

Current Price

0.097

Bid

0.092

Ask

0.097

Volume

8,319

0.097 Day's Range 0.097

0.081 52 Week Range 0.185

Market Cap

34.247M

Previous Close

0.092

Open

0.097

Last Trade

8319

0.097

Last Trade Time

Financial Volume

VWAP

Average Volume (3m)

94,644

Shares Outstanding

353,060,847

Dividend Yield

PE Ratio

-45.71

Earnings Per Share (EPS)

-0

Revenue

Net Profit

-1.24M

Sector

Computer Related Svcs, Nec

Industry

Gold Ores

Website

www.nvoi.com.au

Headquarters

Sydney, New South Wales, Aus

Founded

2016

Novo Resources Corp is listed in the Computer Related Svcs sector of the Australian Stock Exchange with ticker NVO. The last closing price for Novo Resources was AUD0.09. Over the last year, Novo Resources shares have traded in a share price range of AUD 0.081 to AUD 0.185.

Novo Resources currently has 353,060,847 shares outstanding. The market capitalization of Novo Resources is AUD32.48 million. Novo Resources has a price to earnings ratio (PE ratio) of -45.71.

Novo Nordisk Makes Victoza(R) Commercially Available in the United States

PRINCETON, N.J., Feb. 16 /PRNewswire-FirstCall/ -- Novo Nordisk (NYSE: NVO) today announced that Victoza® (liraglutide [rDNA origin] injection...

Novo Nordisk Makes FORTUNE's List of '100 Best Companies to Work For'

Second Consecutive Year for Diabetes Care Leader PRINCETON, N.J., Jan. 21 /PRNewswire-FirstCall/ -- Novo Nordisk, a global healthcare company...

Diabetes and Pre-Diabetes Accounted for $218 Billion in Costs in 2007, Health Affairs Paper Demonstrates

- Novo Nordisk-Funded Analysis Underscores Need to Address Spiraling Diabetes Cost - PRINCETON, N.J., Jan. 14 /PRNewswire/ -- A new analysis...

/K I L L K I L L K I L L - National Changing Diabetes Program/

We are advised by National Changing Diabetes Program that journalists and other readers should disregard the news release, Diabetes and...

Diabetes and Pre-Diabetes Accounted for $218 Billion in Costs in 2007, Health Affairs Paper Demonstrates

- Novo Nordisk-Funded Analysis Underscores Need to Address Spiraling Diabetes Cost - PRINCETON, N.J., Jan. 13 /PRNewswire/ -- A new analysis...

FDA Approves 10 mcg Dose of Vagifem(R) for the Treatment of Atrophic Vaginitis Due to Menopause

Study Shows Relief of Postmenopausal Symptoms PRINCETON, N.J., Dec. 2 /PRNewswire-FirstCall/ -- Novo Nordisk said today that the U.S. Food and...

Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows

Findings Underscore Urgent Need to Reform CBO Scoring of Preventive Care PRINCETON, N.J., Nov. 27 /PRNewswire/ -- The diabetes population in the...

Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows

Findings Underscore Urgent Need to Reform CBO Scoring of Preventive Care PRINCETON, N.J., Nov. 27 /PRNewswire/ -- The diabetes population in the...

Doctors Cite Time, Low Reimbursement As Barriers To Providing Comprehensive Diabetes Care, Survey Results Show

Primary Care Doctors, Endocrinologists Feel Ill-Equipped to Provide Ideal, Multi-Disciplinary Team Care PRINCETON, N.J., Nov. 19 /PRNewswire/...

Novo Nordisk is Changing Possibilities in Hemophilia

Expanded Web Site and Facebook Wall Provide Resources to Hemophilia with Inhibitors Community PRINCETON, N.J., Oct. 30 /PRNewswire-FirstCall/...

Period	Change	Change %	Open	High	Low	Avg. Daily Vol	VWAP
1	0	0	0.097	0.097	0.092	41444	0.09401076	DE
4	0.007	7.77777777778	0.09	0.105	0.089	88904	0.09770858	DE
12	0.004	4.30107526882	0.093	0.105	0.086	94644	0.09430988	DE
26	-0.002	-2.0202020202	0.099	0.14	0.081	129887	0.09724182	DE
52	-0.053	-35.3333333333	0.15	0.185	0.081	127950	0.10798388	DE
156	-0.123	-55.9090909091	0.22	0.275	0.081	158121	0.15597504	DE
260	0.09	1285.71428571	0.007	0.275	0.005	1035228	0.02514028	DE

NVO - Frequently Asked Questions (FAQ)

What is the current Novo Resources share price?

The current share price of Novo Resources is AUD 0.097

How many Novo Resources shares are in issue?

Novo Resources has 353,060,847 shares in issue

What is the market cap of Novo Resources?

The market capitalisation of Novo Resources is AUD 32.48M

What is the 1 year trading range for Novo Resources share price?

Novo Resources has traded in the range of AUD 0.081 to AUD 0.185 during the past year

What is the PE ratio of Novo Resources?

The price to earnings ratio of Novo Resources is -45.71

What is the reporting currency for Novo Resources?

Novo Resources reports financial results in AUD

What is the latest annual profit for Novo Resources?

The latest annual profit of Novo Resources is AUD -1.24M

What is the registered address of Novo Resources?

The registered address for Novo Resources is LEVEL 5, 126 PHILLIP STREET, SYDNEY, NEW SOUTH WALES, 2000

What is the Novo Resources website address?

The website address for Novo Resources is www.nvoi.com.au

Which industry sector does Novo Resources operate in?

Novo Resources operates in the GOLD ORES sector

Symbol	Price	Vol.
EUROBEuropean Lithium Limited	AUD 0.002 (100.00%)	11.2M
H2GGreenHy2 Ltd	AUD 0.006 (100.00%)	8.4M
SFGSeafarms Group Limited	AUD 0.002 (100.00%)	1.7M
RLTRenergen Limited	AUD 0.75 (66.67%)	96.83k
GTRGTI Energy Ltd	AUD 0.003 (50.00%)	1.5M
TSOOATesoro Gold Ltd	AUD 0.003 (-70.00%)	150k
ATVOActiveport Group Ltd	AUD 0.001 (-50.00%)	255k
ASPAspermont Limited	AUD 0.003 (-40.00%)	2.48M
LRDOLord Resources Ltd	AUD 0.004 (-33.33%)	400k
MRDMount Ridley Mines Ltd	AUD 0.002 (-33.33%)	400k
BCBBowen Coking Coal Limited	AUD 0.005 (-9.09%)	66.96M
VAUVault Minerals Ltd	AUD 0.455 (5.81%)	66.69M
TMKTMK Energy Ltd	AUD 0.003 (-14.29%)	47.99M
PNRPantoro Limited	AUD 0.16 (6.67%)	44.69M
NMGNew Murchison Gold Ltd	AUD 0.0155 (3.33%)	43.43M

Symbol

Price

Vol.

BCBBowen Coking Coal Limited

AUD 0.005

(-9.09%)

66.96M

VAUVault Minerals Ltd

AUD 0.455

(5.81%)

66.69M

TMKTMK Energy Ltd

AUD 0.003

(-14.29%)

47.99M

PNRPantoro Limited

AUD 0.16

(6.67%)

44.69M

NMGNew Murchison Gold Ltd

AUD 0.0155

(3.33%)

43.43M

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

Novo Resources Corp (NVO)

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

About Novo Resources Corp

Ask ADVFN Intelligence (AI)

NVO Latest News

Novo Nordisk Makes Victoza(R) Commercially Available in the United States

Novo Nordisk Makes FORTUNE's List of '100 Best Companies to Work For'

Diabetes and Pre-Diabetes Accounted for $218 Billion in Costs in 2007, Health Affairs Paper Demonstrates

/K I L L K I L L K I L L - National Changing Diabetes Program/

Diabetes and Pre-Diabetes Accounted for $218 Billion in Costs in 2007, Health Affairs Paper Demonstrates

FDA Approves 10 mcg Dose of Vagifem(R) for the Treatment of Atrophic Vaginitis Due to Menopause

Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows

Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows

Doctors Cite Time, Low Reimbursement As Barriers To Providing Comprehensive Diabetes Care, Survey Results Show

Novo Nordisk is Changing Possibilities in Hemophilia

NVO - Frequently Asked Questions (FAQ)

Movers

Discussion

Your Recent History

Company

Business

Popular

Get The App

Trending Now

Toplists

Market Data

News

Trading Tools

Markets

Discover

Hot Features

Follow Feed

Options Flow

Monitor

Novo Resources Corp (NVO) Share Price

Novo Resources Corp (NVO)

Real-time discussions and trading ideas: Trade with confidence with our powerful platform.

Key stats and details

About Novo Resources Corp

Ask ADVFN Intelligence (AI)

NVO Latest News

Novo Nordisk Makes Victoza(R) Commercially Available in the United States

Novo Nordisk Makes FORTUNE's List of '100 Best Companies to Work For'

Diabetes and Pre-Diabetes Accounted for $218 Billion in Costs in 2007, Health Affairs Paper Demonstrates

/K I L L K I L L K I L L - National Changing Diabetes Program/

Diabetes and Pre-Diabetes Accounted for $218 Billion in Costs in 2007, Health Affairs Paper Demonstrates

FDA Approves 10 mcg Dose of Vagifem(R) for the Treatment of Atrophic Vaginitis Due to Menopause

Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows

Diabetes Population to Double, Diabetes Costs to Nearly Triple, in 25 Years, New Study Shows

Doctors Cite Time, Low Reimbursement As Barriers To Providing Comprehensive Diabetes Care, Survey Results Show

Novo Nordisk is Changing Possibilities in Hemophilia

NVO - Frequently Asked Questions (FAQ)

Movers

Discussion

Your Recent History

Company

Business

Popular

Get The App

Go Ad-Free